Skip to main content
. 2020 Jul 24;7:116. doi: 10.3389/fcvm.2020.00116

Table 2.

Baseline clinical characteristics in the successful and the unsuccessful revascularization groups.

Total population Propensity-matched population
Successful revascularization (n = 591) Unsuccessful revascularization (n = 1,064) P-value Successful revascularization (n = 371) Unsuccessful revascularization (n = 371) P-value
Age, years 63.0 ± 9.7 64.5 ± 10.4 0.003 63.3 ± 9.3 64.2 ± 10.1 0.280
Male, % 442 (74.8) 850 (79.9) 0.016 281 (75.7) 277 (74.7) 0.734
Smoking, % 239 (40.4) 444 (41.7) 0.610 148 (39.9) 141 (38.0) 0.598
Hypertension, % 388 (65.7) 717 (67.4) 0.473 242 (65.2) 357 (69.3) 0.241
Diabetes mellitus, % 211 (35.7) 381 (35.8) 0.966 135 (36.4) 139 (37.5) 0.761
Dyslipidemia, % 433 (73.3) 777 (73.0) 0.820 280 (75.5) 284 (76.5) 0.731
TC, (m mol/L) 4.54 ± 1.34 4.59 ± 1.28 0.255 4.57 ± 1.36 4.58 ± 1.24 0.831
TG, (m mol/L) 1.61 (1.14–2.41) 1.57 (1.11–2.36) 0.906 1.69 (1.16–2.41) 1.60 (1.09–2.33) 0.532
HDL-C, (m mol/L) 1.30 ± 0.62 1.23 ± 0.49 0.347 1.33 ± 0.69 1.19 ± 0.37 0.207
LDL-C, (m mol/L) 2.62 ± 0.92 2.72 ± 0.90 0.056 2.62 ± 0.91 2.72 ± 0.88 0.322
Familial history of CAD, % 83 (14.0) 134 (12.6) 0.402 48 (12.9) 49 (13.2) 0.913
Previous MI, % 241 (40.8) 543 (51.0) <0.001 161 (43.4) 169 (45.6) 0.555
Previous PCI, % 77 (13.0) 120 (11.3) 0.292 45 (12.1) 40 (10.8) 0.564
CKD, % 33 (5.6) 109 (10.5) 0.001 22 (5.9) 32 (8.6) 0.158
LVEF, % 53.9 ± 8.4 52.1 ± 9.3 0.002 53.6 ± 8.5 56.6 ± 8.7 0.474
Stable angina, % 148 (25.0) 335 (31.5) 0.006 100 (26.9) 109 (29.4) 0.463
UA/NSTEMI, % 336 (56.8) 486 (45.7) <0.001 199 (53.6) 178 (48.1) 0.123
Baseline medication
Aspirin, % 578 (97.8) 1,042 (97.9) 0.858 361 (97.3) 365 (98.4) 0.312
Clopidogrel, % 554 (93.7) 969 (91.1) 0.055 346 (93.3) 332 (89.5) 0.067
Statin, % 555 (93.9) 1,008 (94.7) 0.482 350 (94.3) 347 (93.5) 0.644
β blocker, % 438 (74.1) 804 (75.6) 0.513 279 (75.2) 276 (74.4) 0.800
ACEI or ARB, % 341 (57.7) 691 (64.9) 0.004 206 (55.5) 211 (56.9) 0.711

ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin-receptor blocker; CAD, coronary artery disease; CKD, chronic kidney disease; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; LVEF, left ventricular ejection fraction; MI, myocardial infarction; NSTEMI, non-ST elevation myocardial infarction; PCI, percutaneous coronary intervention; TC, total cholesterol; TG, total triglyceride; UA, unstable angina.